| Year |
Citation |
Score |
| 2016 |
Cao L, Wagar EA, Meng QH. A young boy with recurrent headache, lethargy, and hyponatremia. Clinica Chimica Acta; International Journal of Clinical Chemistry. 454: 46-8. PMID 26747959 DOI: 10.1016/J.Cca.2015.12.038 |
0.324 |
|
| 2015 |
Condello S, Morgan CA, Nagdas S, Cao L, Turek J, Hurley TD, Matei D. β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene. 34: 2297-308. PMID 24954508 DOI: 10.1038/Onc.2014.178 |
0.538 |
|
| 2013 |
Wang C, Li Y, Zhang H, Liu F, Cheng Z, Wang D, Wang G, Xu H, Zhao Y, Cao L, Li F. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis. Oncogene. 33: 3473-84. PMID 23934187 DOI: 10.1038/Onc.2013.300 |
0.308 |
|
| 2013 |
Condello S, Cao L, Matei D. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 3100-12. PMID 23640056 DOI: 10.1096/Fj.12-222620 |
0.585 |
|
| 2013 |
Wang L, Zhang H, Rodriguez-Rodriguez S, Cao L, Parish J, Zollman A, Kamocka M, Boswell HS, Srour EF, Chitteti BR, Manshouri T, Verstovsek S, Kapur R, Cardoso AA, Carlesso N. Loss Of Canonic Notch Signaling In The Microenvironment Causes a Myeloproliferative Syndrome Via Derepression Of The miR155 Promoter Blood. 122: 339-339. DOI: 10.1182/Blood.V122.21.339.339 |
0.318 |
|
| 2013 |
Condello S, Cao L, Matei D. Abstract C49: Tissue tranglutaminase regulates β-catenin signaling in ovarian cancer cells Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C49 |
0.592 |
|
| 2012 |
Cao L, Shao M, Schilder J, Guise T, Mohammad KS, Matei D. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene. 31: 2521-34. PMID 21963846 DOI: 10.1038/Onc.2011.429 |
0.599 |
|
| 2012 |
Schmitt J, Thomas M, Caperell-Grant A, Chelladurai B, Cao L, Mehtala J, Perkins S, Wei A, Matei D. Abstract 3439: Tissue tranglutaminase (TG2) targeting by multifunctional field responsive gold nanoparticles Cancer Research. 72: 3439-3439. DOI: 10.1158/1538-7445.Am2012-3439 |
0.596 |
|
| 2010 |
Mayeenuddin LH, Yu Y, Kang Z, Helman LJ, Cao L. Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L). Oncogene. 29: 6367-77. PMID 20818434 DOI: 10.1038/onc.2010.364 |
0.305 |
|
| 2009 |
Shao M, Cao L, Shen C, Satpathy M, Chelladurai B, Bigsby RM, Nakshatri H, Matei D. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Research. 69: 9192-201. PMID 19951993 DOI: 10.1158/0008-5472.Can-09-1257 |
0.607 |
|
| 2008 |
Cao L, Petrusca DN, Satpathy M, Nakshatri H, Petrache I, Matei D. Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis. 29: 1893-900. PMID 18667446 DOI: 10.1093/Carcin/Bgn158 |
0.577 |
|
| 2007 |
Matei D, Kelich S, Cao L, Menning N, Emerson RE, Rao J, Jeng MH, Sledge GW. PDGF BB induces VEGF secretion in ovarian cancer. Cancer Biology & Therapy. 6: 1951-9. PMID 18075302 DOI: 10.4161/Cbt.6.12.4976 |
0.582 |
|
| 2007 |
Satpathy M, Cao L, Pincheira R, Emerson R, Bigsby R, Nakshatri H, Matei D. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Research. 67: 7194-202. PMID 17671187 DOI: 10.1158/0008-5472.Can-07-0307 |
0.599 |
|
| 2007 |
Matei D, Satpathy M, Cao L, Lai YC, Nakshatri H, Donner DB. The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells. The Journal of Biological Chemistry. 282: 445-53. PMID 17079230 DOI: 10.1074/Jbc.M607012200 |
0.524 |
|
| Show low-probability matches. |